Enanta Pharmaceuticals Inc (NAS:ENTA)
$ 11.26 0.15 (1.35%) Market Cap: 238.58 Mil Enterprise Value: 55.89 Mil PE Ratio: 0 PB Ratio: 1.60 GF Score: 61/100

Enanta Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 04:30PM GMT
Release Date Price: $26.3 (+1.70%)
Akash Tewari
Jefferies - Analyst

Good morning, everyone. I hope you're enjoying day one of our Jefferies Healthcare Conference. For those who don't know me, my name is Akash Tewari, I'm one of the biotech analysts here. I have the pleasure of hosting the Enanta management team. Why don't I hand it off to Jay and Tara to give some brief introductions and then we'll get into some Q&A.

Jay Luly
Enanta Pharmaceuticals, Inc. - President, CEO, & Director

Sure. Before we begin, I want to remind you that I'll be making some forward-looking statements today. For a summary of the risks associated with these statements, please see our filings on sec.gov and on our website. So I'm Jay Luly, I'm President and CEO of Enanta. I'm sorry, Akash, you just wanted to do name introduction.

Akash Tewari;Jay Luly
Jefferies - Analyst;Enanta Pharmaceuticals, Inc. - President, CEO, & Director

I mean, if you want to give any introductory remarks sure, but otherwise we can get into Q&A.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot